Diabetes Mellitus

An authoritative clinical profile of Diabetes Mellitus covering ADA 2024 diagnostic criteria (HbA1c ≥6.5%), microvascular and macrovascular complications, DKA/HHS and severe hypoglycemia emergency red flags, and insulin non-discontinuation boundaries.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

System AffinityGeneral
Diagnostic StandardClinical evaluation & serum biomarkers
Urgency Levelroutine
Evidence GradeConsensus-Guidance

Visual guide

Transparent upper-abdomen anatomy showing the pancreas, liver, stomach, and surrounding structures
Homeo Healthcare
Understanding the pancreas
Indian woman writing her own questions in a notebook in a bright community health-centre lounge
Homeo Healthcare
A patient-owned preparation moment
Abstract translucent islet-inspired core with coral and gold spheres moving through aqua glass pathways
Homeo Healthcare
A closer look at signalling

In simple words

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both [D0010-KEYNOTES, CIT-0040]. It is diagnosed by fasting plasma glucose ≥126 mg/dL, 2-hour OGTT ≥200 mg/dL, or HbA1c ≥6.5%.

What it means

A chronic metabolic disease of impaired carbohydrate, fat, and protein metabolism leading to systemic microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (coronary artery disease, peripheral arterial disease, stroke) damage.

Common causes

  • Type 1 Diabetes Mellitus: Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency [D0010-KEYNOTES, CIT-0040]
  • Type 2 Diabetes Mellitus: Progressive insulin resistance combined with compensatory beta-cell dysfunction
  • Gestational Diabetes Mellitus and secondary forms (pancreatitis, Cushing syndrome, drug-induced)

Risk Factors

  • Overweight/obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian populations) and abdominal visceral adiposity
  • Physical inactivity, high glycemic diet, and first-degree relative with Type 2 Diabetes
  • History of gestational diabetes, polycystic ovary syndrome (PCOS), or hypertension (≥130/80 mmHg)

Common symptoms

  • Classic triad: Polyuria (frequent urination), polydipsia (excessive thirst), and polyphagia (excessive hunger) with unmanaged weight loss [D0010-KEYNOTES, CIT-0040]
  • Fatigue, blurred vision, slow-healing cutaneous wounds, and recurrent genitourinary fungal infections
  • Peripheral distal symmetric paresthesias ('glove and stocking' numbness and tingling)

Lifestyle & diet support

Adhere to a low glycemic index diet, engage in 150 minutes/week of moderate aerobic exercise, perform daily foot self-inspections, and keep glucose logbooks.

Treatment Approaches

Conventional Management

Therapy involves medical nutrition therapy, physical activity, glucose self-monitoring, metformin as first-line pharmacotherapy, SGLT2 inhibitors / GLP-1 receptor agonists for cardiorenal protection, and basal-bolus insulin regimens [CIT-0040].

Homeopathic Approach

Homeopathic care serves as a complementary lifestyle and constitutional approach to improve metabolic wellness, reduce neuropathic discomforts, and support vitality under continuous blood glucose monitoring.

Frequently Asked Questions

DKA and HHS are life-threatening acute metabolic emergencies [D0010-EMERGENCY-LIMITS, CIT-0040]. DKA presents with blood glucose >250 mg/dL, arterial pH <7.30, serum ketones, Kussmaul breathing, and fruity acetone breath odor. HHS presents with blood glucose >600 mg/dL and severe dehydration. Both require IMMEDIATE emergency medical transport for IV fluid resuscitation, continuous insulin infusion, and electrolyte monitoring.
NO. Insulin in Type 1 Diabetes and prescribed hypoglycemic medications in Type 2 Diabetes MUST NEVER be discontinued or reduced without direct medical supervision [D0010-REGULATORY-LIMITS]. Abrupt insulin cessation causes fatal DKA.
Homeopathy acts as a supportive constitutional modality for overall vitality and symptom relief while glycemic control is strictly managed with standard medical care and regular HbA1c testing [D0010-REGULATORY-LIMITS].
Clinical & academic detailShow detail

Diagnosis & tests

Investigation Protocol

Diagnosed via venous plasma fasting blood glucose ≥126 mg/dL (7.0 mmol/L), HbA1c ≥6.5% (48 mmol/mol), or random plasma glucose ≥200 mg/dL (11.1 mmol/L) with classic hyperglycemic symptoms, confirmed by repeat testing [CIT-0040].

Differential Diagnosis

Differentiate Type 1 T1DM from Type 2 T2DM, Monogenic Diabetes (MODY), LADA (Latent Autoimmune Diabetes in Adults), Diabetes Insipidus, and secondary drug-induced hyperglycemia.

Differential Diagnosis Matrix

Differential Diagnosis Overview

Differentiate Type 1 T1DM from Type 2 T2DM, Monogenic Diabetes (MODY), LADA (Latent Autoimmune Diabetes in Adults), Diabetes Insipidus, and secondary drug-induced hyperglycemia.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0040American Diabetes Association Professional Practice Committee. "Standards of Care in Diabetes—2024." Diabetes Care (2024).
Materia Medica & Keynotes
  • CIT-0004Hahnemann S.. "Materia Medica Pura." Adolph Arnold (1811).
  • CIT-0005Kent J. T.. "Lectures on Homoeopathic Materia Medica." Boericke & Tafel (1905).
  • CIT-0006Boericke W.. "Pocket Manual of Homoeopathic Materia Medica." Boericke & Runyon (1901).

No clinical connections registered for this topic.

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.